Prevail and Alector founder Asa Abeliovich (file photo)
November 3, 2020 10:55 AM ESTUpdated 02:32 PM
People
Pharma

Pre­vail and Alec­tor both claim vic­to­ry in ar­bi­tra­tion over sci­en­tist-CEO, telling di­ver­gent tales of con­fi­den­tial hear­ings

Jason Mast

Editor

At 7 am Mon­day, Pre­vail Ther­a­peu­tics an­nounced their CEO “de­ci­sive­ly” won a year-plus-long ar­bi­tra­tion bat­tle over trade se­crets with his …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Why did Eli Lil­ly ask a pa­tient on a com­pound­ed GLP-1 drug for their med­ical in­for­ma­tion?

FDA OKs the first-ever self-ad­min­is­tered vac­cine, for flu

The drug lob­by's law­suit against the IRA finds a sign of life af­ter ap­peals court rul­ing

Biotech VC firm out­lines plans for $100M fund

FTC to sue ma­jor PBMs over in­sulin re­bates, claim­ing they in­flat­ed pa­tient cost

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times